会员体验
专利管家(专利管理)
工作空间(专利管理)
风险监控(情报监控)
数据分析(专利分析)
侵权分析(诉讼无效)
联系我们
交流群
官方交流:
QQ群: 891211   
微信请扫码    >>>
现在联系顾问~
热词
    • 9. 发明申请
    • Nucleobase phosphonate analogs for antiviral treatment
    • 用于抗病毒治疗的核碱基膦酸酯类似物
    • US20050059637A1
    • 2005-03-17
    • US10903288
    • 2004-07-30
    • Steven Krawczyk
    • Steven Krawczyk
    • C07F9/6561A61K31/675
    • C07F9/65616A61K31/675
    • The present invention provides novel compounds with activity against infectious viruses. The compounds of the invention may inhibit retroviral reverse transcriptases and thus inhibit the replication of the virus. They are useful for treating human patients infected with a human retrovirus, such as human immunodeficiency virus (strains of HIV-1 or HIV-2) or human T-cell leukemia viruses (HTLV-I or HTLV-II) which results in acquired immunodeficiency syndrome (AIDS) and/or related diseases. The present invention also relates generally to the accumulation or retention of therapeutic compounds inside cells. The invention is more particularly related to attaining high concentrations of active metabolite molecules in HIV infected cells. Intracellular targeting may be achieved by methods and compositions which allow accumulation or retention of biologically active agents inside cells. Such effective targeting may be applicable to a variety of therapeutic formulations and procedures.
    • 本发明提供具有抗感染性病毒活性的新型化合物。 本发明的化合物可以抑制逆转录病毒逆转录酶,从而抑制病毒的复制。 它们可用于治疗感染人类逆转录病毒的人类患者,例如导致获得性免疫缺陷的人类免疫缺陷病毒(HIV-1或HIV-2的菌株)或人T细胞白血病病毒(HTLV-1或HTLV-II) 综合征(AIDS)和/或相关疾病。 本发明一般还涉及细胞内治疗化合物的积聚或保留。 本发明更具体地涉及在HIV感染细胞中获得高浓度的活性代谢物分子。 细胞内靶向可以通过允许生物活性剂在细胞内积累或保留的方法和组合物来实现。 这种有效靶向可以适用于多种治疗剂型和方法。
    • 10. 发明申请
    • Nucleobase phosphonate analogs for antiviral treatment
    • 用于抗病毒治疗的核碱基膦酸酯类似物
    • US20060252729A1
    • 2006-11-09
    • US10566819
    • 2004-07-30
    • Steven Krawczyk
    • Steven Krawczyk
    • C07F9/6512A61K31/675
    • C07F9/65616A61K31/675
    • The present invention provides novel compounds with activity against infectious viruses. The compounds of the invention may inhibit retroviral reverse transcriptases and thus inhibit the replication of the virus. They are useful for treating human patients infected with a human retrovirus, such as human immunodeficiency virus (strains of HIV-1 or HIV-2) or human T-cell leukemia viruses (HTLV-I or HTLV-II) which results in acquired immunodeficiency syndrome (AIDS) and/or related diseases. The present invention also relates generally to the accumulation or retention of therapeutic compounds inside cells. The invention is more particularly related to attaining high concentrations of active metabolite molecules in HIV infected cells. Intracellular targeting may be achieved by methods and compositions which allow accumulation or retention of biologically active agents inside cells. Such effective targeting may be applicable to a variety of therapeutic formulations and procedures.
    • 本发明提供具有抗感染性病毒活性的新型化合物。 本发明的化合物可以抑制逆转录病毒逆转录酶,从而抑制病毒的复制。 它们可用于治疗感染人类逆转录病毒的人类患者,例如导致获得性免疫缺陷的人类免疫缺陷病毒(HIV-1或HIV-2的菌株)或人T细胞白血病病毒(HTLV-1或HTLV-II) 综合征(AIDS)和/或相关疾病。 本发明一般还涉及细胞内治疗化合物的积聚或保留。 本发明更具体地涉及在HIV感染细胞中获得高浓度的活性代谢物分子。 细胞内靶向可以通过允许生物活性剂在细胞内积累或保留的方法和组合物来实现。 这种有效靶向可以适用于多种治疗剂型和方法。